Psychiatry and Neurology, Neurology · Carlsbad, CA
NPI
1396921144
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6010 Hidden Valley Rd Ste 200
Carlsbad, CA, 92011
Phone (760) 631-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$347K
43,798 services
Medicare patients, 2024
555
Average age 69
Drug cost, 2024
$2.4M
3,866 prescriptions
Company payments, 2025
$54K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bilal A Choudry was code J0585 (injection, onabotulinumtoxina, 1 unit), 42,410 times for 94 patients. In total Bilal A Choudry billed 43,798 services in 39 codes, and Medicare paid $347K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 42,410 | 94 | $4.91 | $208K |
| 99214 Office E&M - Established | Office | 267 | 214 | $95.03 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 244 | 176 | $12.67 | $3,091 |
| 64615 Musculoskeletal | Office | 213 | 93 | $125.70 | $27K |
| 99213 Office E&M - Established | Office | 198 | 155 | $67.27 | $13K |
| 99215 Office E&M - Established | Office | 131 | 116 | $141.59 | $19K |
| 95708 Neurologic | Office | 42 | 39 | $257.19 | $11K |
| 99205 Office E&M - New | Office | 41 | 41 | $163.24 | $6,693 |
| 95700 Neurologic | Office | 39 | 39 | $231.65 | $9,034 |
| 95719 Neurologic | Office | 37 | 37 | $132.89 | $4,917 |
| 95970 Electrical Nerve Conductivity | Office | 29 | 13 | $13.80 | $400 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 25 | 14 | $25.54 | $638 |
| 95819 Neurologic | Office | 21 | 21 | $415.62 | $8,728 |
| 95816 Neurologic | Office | 15 | 15 | $347.60 | $5,214 |
By year: 2022 $232K for 28,989 services; 2023 $270K for 31,767 services; 2024 $347K for 43,798 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bilal A Choudry prescribed most often to Medicare patients was Levetiracetam, with 513 prescriptions and refills. In total Bilal A Choudry wrote 3,866 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 513 | 1,141 | 122 | $26K |
| Briviact Brivaracetam | 346 | 376 | 39 | $511K |
| Lacosamide Generic | 318 | 384 | 51 | $37K |
| Lamotrigine Generic | 286 | 613 | 60 | $6,196 |
| Gabapentin Generic | 188 | 296 | 54 | $2,736 |
| Aptiom Eslicarbazepine Acetate | 178 | 206 | 23 | $372K |
| Levetiracetam Er Levetiracetam | 119 | 304 | 30 | $13K |
| Divalproex Sodium Er Divalproex Sodium | 117 | 149 | Under 11 | $6,224 |
| Clobazam Generic | 114 | 141 | 21 | $9,861 |
| Clonazepam Generic | 109 | 109 | 15 | $986 |
| Xcopri Cenobamate | 106 | 107 | 14 | $148K |
| Lamotrigine Er Lamotrigine | 88 | 167 | 13 | $22K |
| Topiramate Generic | 87 | 183 | 18 | $1,046 |
| Vimpat Lacosamide | 78 | 91 | Under 11 | $104K |
| Epidiolex Cannabidiol (Cbd) | 77 | 78 | Under 11 | $555K |
Brand drugs: 1,158 claims; generic drugs: 2,666 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bilal A Choudry $54K ($54K in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 87 | $18K |
| Jazz Pharmaceuticals Inc. JAZZ | 27 | $14K |
| SK Life Science, Inc. | 54 | $11K |
| UCB, Inc. UCB.BR | 49 | $9,827 |
| Neurelis, Inc. | 23 | $453 |
| Pfizer Inc. PFE | 33 | $312 |
| Neurocrine BioSciences, Inc. NBIX | 15 | $261 |
| Neuropace, Inc. NPCE | 5 | $157 |
| Axsome Therapeutics, Inc. AXSM | 4 | $155 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $90.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.